Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Acute Kidney Injury

Jul 3, 2016/Clinical Summary

PTs have a role in screening, examining, and providing intervention with this patient population in order to help minimize deleterious effects of bedrest and optimize movement.

The Future of DPT Education Post COVID-19

Jun 1, 2021/Feature

Part two of APTA Magazine’s special issue on physical therapist education continues the exclusive interview with four academic leaders.

I’m Living With the Uncertainty of Long COVID. Connecting With Others Is Critical

Mar 15, 2021/Perspective

Here's what it's been like for me.

IMPROVE VTE Risk Model

Oct 31, 2021/Test & Measure

The IMPROVE VTE Risk Model is an assessment tool that is used to discriminate risk of developing validated venous thromboembolism (VTE) in patients who are critically ill, based on clinical variables.1

Rate Your Plate (RYP)

Sep 7, 2022/Test & Measure

COVID-19 Research Updates and Perspectives

May 1, 2020/Roundup

A collection of recently published studies and opinion pieces relevant to COVID-19.

APTA Wants To Hear From You About Your COVID-19 Experiences

Apr 1, 2020/News

Are you on the frontlines of the COVID-19 pandemic? APTA would like to hear from PTs, PTAs, and students about their experiences.

APTA, Lawmakers Press for Payment Relief by March 11 Deadline

Mar 8, 2022/News

Remember that old saying, "strike while the iron is hot"? Things are hot on Capitol Hill (and there's still time to act).

APTA Components Step up to the COVID-19 Challenge With Ever-Growing Resources

Mar 25, 2020/News

  From helping physical therapy faculty move their courses online to conducting a webinar on providing acute care physical therapy during a pandemic, association chapters and sections are keeping the profession informed and creating an impressive array of tools.   "We are going through this, day by day,

More Physical Activity Linked to Better COVID-19 Outcomes

Jan 13, 2023/Review

Authors found a dose-response relationship between PA and adverse COVID-19 events that was consistent across multiple subgroups.